Ryan White HIV/AIDS Program HIV Care Grant Program – Part B States/Territories Formula and AIDS Drug Assistance Program Formula and ADAP Supplemental Awards
This funding opportunity provides financial support to state governments and U.S. territories to improve access to HIV care and treatment for low-income individuals living with HIV.
The Ryan White HIV/AIDS Program HIV Care Grant Program – Part B States/Territories Formula and AIDS Drug Assistance Program Formula and ADAP Supplemental Awards is administered by the U.S. Department of Health and Human Services through the Health Resources and Services Administration HIV/AIDS Bureau. This program represents a major federal investment in improving access to HIV care and treatment across the United States and its territories. It is authorized under the Public Health Service Act and supports national goals to reduce HIV transmission, improve health outcomes, and address disparities among people living with HIV. The purpose of this funding opportunity is to assist states and territories in developing and enhancing a comprehensive system of HIV care for low-income individuals. The program supports a continuum of care that includes core medical services, supportive services, and access to medications through the AIDS Drug Assistance Program. Funds are intended to expand access, improve retention in care, and support viral suppression outcomes. Recipients must conduct needs assessments and use data-driven planning to identify service gaps and improve care delivery systems. Funding under this program is distributed primarily through formula-based allocations tied to the number of people living with HIV in each jurisdiction. The program includes several components: Part B Base funding, ADAP Base funding, ADAP Supplemental funding, Minority AIDS Initiative funding, and Emerging Communities funding. The total estimated program funding is approximately 1.34 billion dollars annually, supporting up to 59 awards. Award amounts vary by formula and jurisdiction rather than fixed grant sizes. Funds must be used in accordance with strict federal requirements. At least 75 percent of funds, excluding administrative and planning costs, must be allocated to core medical services. Allowable uses include outpatient care, medications, and support services that enable access to treatment. Recipients must also comply with payer of last resort requirements, ensuring that federal funds do not duplicate other available coverage such as Medicaid or private insurance. Maintenance of effort provisions require states to sustain prior levels of non-federal HIV-related spending. Eligibility is limited to state governments and U.S. territories, including the 50 states, District of Columbia, Puerto Rico, and several Pacific and Caribbean territories. Applicants must designate a lead agency responsible for administering funds, conducting planning processes, and ensuring compliance with reporting and audit requirements. Additional eligibility criteria apply for specific funding components such as ADAP Supplemental awards, which require demonstration of financial or service capacity challenges. The application process requires submission through Grants.gov using the SF-424 application package. Applicants must include a project abstract, detailed narrative, budget, needs assessment data, and implementation plan. The application deadline for this funding cycle was November 8, 2021, with an issuance date of July 23, 2021. The program operates on a five-year period of performance from April 1, 2022 through March 31, 2027, with annual non-competing continuation reports required after the initial award year. Applications are reviewed based on compliance with statutory requirements, completeness, and alignment with program objectives. Ongoing monitoring includes fiscal and programmatic oversight, clinical quality management requirements, and reporting on outcomes such as viral suppression and care retention. For questions or technical assistance, applicants may contact Susan Robilotto at HRSA via email or phone as listed in the notice.
Award Range
Not specified - Not specified
Total Program Funding
$1,340,000,000
Number of Awards
59
Matching Requirement
Yes - Varies; typically $1 non-federal per $5 federal increasing to $1 per $2; ADAP Supplemental requires $1 per $4
Additional Details
Formula-based awards; multi-component funding including Part B Base, ADAP Base, Supplemental, MAI, and EC; five-year period of performance (2022-2027); at least 75 percent must be used for core medical services
Eligible Applicants
Additional Requirements
Eligible applicants are limited to U.S. state and territorial governments including the 50 states, District of Columbia, Puerto Rico, Northern Mariana Islands, American Samoa, Guam, U.S. Virgin Islands, Federated States of Micronesia, Republic of the Marshall Islands, and Republic of Palau. Applicants must designate a lead agency responsible for administering funds, conducting needs assessments, and ensuring compliance with federal requirements. Additional eligibility criteria apply for specific components such as ADAP Supplemental funding, including financial and service capacity conditions.
Geographic Eligibility
All
Ensure strong data-driven needs assessment and alignment with HIV care continuum; prioritize core medical services spending compliance; demonstrate payer of last resort procedures and coordination with other coverage sources; include detailed implementation and quality management plans
Application Opens
July 23, 2021
Application Closes
November 8, 2021
Grantor
Susan Robilotto
Subscribe to view contact details
Subscribe to access grant documents


